{"url_path":"/sec/bglc/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1737523/0001477932-26-003242-index.html","accession_number":"0001477932-26-003242","cik":"0001737523","ticker":"BGLC","issuer_name":"BioNexus Gene Lab Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737523/0001477932-26-003242-index.html","primary_entity_key":"0001737523","primary_entity_name":"BioNexus Gene Lab Corp"},"word_count":75,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors.**\n\n \n\nThere have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The risk factors described in our Form 10-K for the fiscal year ended December 31, 2025 should be carefully considered, as they could materially affect our business, financial condition, and results of operations.\n\n \n\n \n\n42\n\n*Table of Contents*"}